Aurobindo Pharma Ltd has recalled 2,352 bottles of lipid-lowering Simvastatin tablets from the US market, according information available with the US Food and Drug Administration. According to the US Regulator, this was a ‘voluntary recall’. The drug was manufactured by the US arm of Hyderabad-based Aurobindo, Aurolife Pharma LLC, the USFDA said. The reason for has been mentioned as “labelling; incorrect or missing lot and/or exp date,” the US regulator said. The product was distributed nationwide by three major distributors who may have further distributed the product, the report said.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.